The Library
Browse by Warwick Author
Up a level |
Number of items: 86.
Journal Article
Azam, Ayesha S., Tsang, YeeβWah, Thirlwall, Jenny, Kimani, Peter K., Sah, Shatrughan, Gopalakrishnan, Kishore, Boyd, Clinton, Loughrey, Maurice B., Kelly, Paul J., Boyle, David P. et al.
(2024)
Digital pathology for reporting histopathology samples, including cancer screening samples β definitive evidence from a multisite study.
Histopathology
.
doi:10.1111/his.15129
ISSN 0309-0167.
Quenby, Siobhan, Booth, Katie, Hiller, Louise, Coomarasamy, Arri, de Jong, Paulien G., HamulyΓ‘k, Eva N., Scheres, Luuk J., van Haaps, Thijs F., Ewington, Lauren J., Tewary, Shreeya, Goddijn, MariΓ«tte and Middeldorp, Saskia (2023) Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2) : an international open-label, randomised controlled trial. Lancet, 402 (10395). pp. 54-61. doi:10.1016/S0140-6736(23)00693-1 ISSN 0140-6736.
Sudin, Ellhia, Searjeant, Mitchell, Partridge, George, Phillips, Peter W., Hiller, Louise, Snead, David R. J., Ellis, Ian O. and Chen, Yan (2022) Digital pathology : the effect of experience on visual search behavior. Journal of Medical Imaging , 9 (03). 035501. doi:10.1117/1.JMI.9.3.035501 ISSN 2329-4302.
Sammut, S., Crispin-Ortuzar, M., Chin, S. F., Provenzano, E., Bardwell, H. A., Ma, W., Cope, W., Dariush, A., Dawson, S. J., Abraham, J. et al.
(2022)
Multi-omic machine learning predictor of breast cancer therapy response.
Nature, 601
.
pp. 623-629.
doi:10.1038/s41586-021-04278-5
ISSN 0028-0836.
I-SPY 2 TRIAL Consortium (Including:
Yao, C., Osdoit, M., van der Noordaa, M., Shad, S., Wei, J., de Croze, D., Hamy, A -S., LaΓ©, M., Reyal, F., Sonke, G. S. et al.
).
(2022)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer : a multicentre pooled analysis of 5161 patients.
Lancet Oncology, 23
(1).
pp. 149-160.
doi:10.1016/S1470-2045(21)00589-1
ISSN 1470-2045.
Earl, Helena M., Hiller, Louise, Dunn, Janet A., Macpherson, Iain, Rea, Daniel, Hughes-Davies, Luke, McAdam, Karen , Hall, Peter, Mansi, Janine , Wheatley, Duncan, Abraham, Jean, Caldas, Carlos, Gasson, Sophie, O'Riordan, Liz, Wilcox, Maggie, Miles, David , Cameron , David and Wardley, Andrew (2021) Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK. Clinical Oncology, 33 (1). pp. 15-19. doi:10.1016/j.clon.2020.07.006 ISSN 0936-6555.
Earl, Helena, Hiller, Louise, Vallier, Anne-Laure, Loi, Shrushma, McAdam, Karen, Hughes-Davies, Luke, Rea, Daniel, Howe, Donna L., Raynes, Kerry, Higgins, Helen B. et al.
(2020)
Six versus 12 monthsβ adjuvant trastuzumab in patients with HER2-positive early breast cancer : the PERSEPHONE non-inferiority RCT.
Health Technology Assessment, 24
(40).
pp. 1-190.
doi:10.3310/hta24400
ISSN 1366-5278.
Earl, Helena M., Hiller, Louise, Vallier, Anne-Laure, Loi, Shrushma, McAdam, Karen, Hughes-Davies, Luke, Harnett, Adrian N, Ah-See, Mei-Lin, Simcock, Richard, Rea, Daniel et al.
(2019)
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE) : 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
The Lancet, 393
(10191).
pp. 2599-2612.
doi:10.1016/S0140-6736(19)30650-6
ISSN 0140-6736.
Escala-Garcia, Maria, Guo, Qi, DΓΆrk, Thilo, Canisius, Sander, Keeman, Renske, Dennis, Joe, Beesley, Jonathan, Lecarpentier, Julie, Bolla, Manjeet K., Wang, Qin et al.
(2019)
Genome-wide association study of germline variants and breast cancer-specific mortality.
British Journal of Cancer, 120
(6).
pp. 647-657.
doi:10.1038/s41416-019-0393-x
ISSN 0007-0920.
Hiller, Louise, Dunn, Janet A., Loi, Shrushma, Vallier, Anne-Laure, Howe, Donna L., Cameron, David A., Miles, David, Wardley, Andrew M. and Earl, Helena M. (2018) Adjuvant trastuzumab duration trials in HER2 positive breast cancer : what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results. BMC Cancer, 18 . 391. doi:10.1186/s12885-018-4307-8 ISSN 1471-2407.
Guo, Qi, Burgess, Stephen, Turman, Constance, Bolla, Manjeet K., Wang, Qin, Lush, Michael, Abraham, Jean, AittomΓ€ki, Kristiina, Andrulis, Irene L, Apicella, Carmel et al.
(2017)
Body mass index and breast cancer survival : a Mendelian randomization analysis.
International Journal of Epidemiology, 46
(6).
pp. 1814-1822.
doi:10.1093/ije/dyx131
ISSN 0300-5771.
Earl, H. M., Hiller, Louise, Dunn, Janet A., Blenkinsop, C., Grybowicz, L., Vallier, A.-L., Gounaris, I., Abraham, J. E., Hughes-Davies, L., McAdam, K. et al.
(2017)
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer : ARTemis Trial.
Annals of Oncology, 28
(8).
pp. 1817-1824.
doi:10.1093/annonc/mdx173
ISSN 0923-7534.
Ali, H. R., Dariush, A., Thomas, J., Provenzano, E., Dunn, Janet A., Hiller, Louise, Vallier, A.-L., Abraham, J., Piper, T., Bartlett, J. M. S., Cameron, D. A., Hayward, L., Brenton, J. D., Pharoah, P. D. P., Irwin, M. J., Walton, N. A., Earl, H. M. and Caldas, C. (2017) Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer : secondary analysis of the ARTemis trial. Annals of Oncology, 28 (8). pp. 1832-1835. doi:10.1093/annonc/mdx266 ISSN 0923-7534.
Earl, Helena M., Hiller, Louise, Howard, Helen C., Dunn, Janet A., Young, Jennie, Bowden, Sarah J., McDermaid, Michelle, Waterhouse, Anna K., Wilson, Gregory, Agrawal, Rajiv et al.
(2017)
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo) : final 10-year follow-up of an open-label, randomised, phase 3 trial.
The Lancet Oncology, 18
(6).
pp. 755-769.
doi:10.1016/S1470-2045(17)30319-4
ISSN 1470-2045.
Thomas, Jeremy St John, Provenzano, Elena, Hiller, Louise, Dunn, Janet A., Blenkinsop, Clare, Grybowicz, Louise, Vallier, Anne-Laure, Gounaris, Ioannis, Abraham, Jean, Hughes-Davies, Luke et al.
(2017)
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.
Modern Pathology, 30
(8).
pp. 1069-1077.
doi:10.1038/modpathol.2017.30
ISSN 0893-3952.
Ali, H. Raza, Dariush, Aliakbar, Provenzano, Elena, Bardwell, Helen, Abraham, Jean E., Iddawela, Mahesh, Vallier, Anne-Laure, Hiller, Louise, Dunn, Janet A., Bowden, Sarah J., Hickish, Tamas, McAdam, Karen, Houston, Stephen, Irwin, Mike J., Pharoah, Paul D. P., Brenton, James D., Walton, Nicholas A., Earl, Helena M. and Caldas, Carlos (2016) Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research, 18 (1). 21. doi:10.1186/s13058-016-0682-8 ISSN 1465-542X.
Earl, Helena M, Vallier, Anne-Laure, Dunn, Janet A., Loi, Shrushma, Ogburn, Emma, McAdam, Karen, Hughes-Davies, Luke, Harnett, Adrian, Abraham, Jean, Wardley, Andrew, Cameron, David A, Miles, David, Gounaris, Ioannis, Plummer, Chris and Hiller, Louise (2016) Trastuzumab-associated cardiac events in the Persephone trial. British Journal of Cancer, 115 (12). pp. 1462-1470. doi:10.1038/bjc.2016.357 ISSN 0007-0920.
Dorling, L, Kar, Siddhartha, Michailidou, Kyriaki, Hiller, Louise, Vallier, Anne-Laure, Ingle, Susan, Hardy, Richard, Bowden, Sarah J., Dunn, Janet A., Twelves, Chris, Poole, Christopher J., Caldas, Carlos, Earl, Helena M., Pharoah, Paul D. P. and Abraham, Jean E. (2016) The relationship between common genetic markers of breast cancer risk and chemotherapy-induced toxicity : a case-control study. PLoS One, 11 (7). e0158984. doi:10.1371/journal.pone.0158984 ISSN 1932-6203.
Scott, R. A., Freitag, D. F., Li, L., Chu, A. Y., Surendran, P., Young, R., Grarup, N., Stancakova, A., Chen, Y., Varga, T. V. et al.
(2016)
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.
Science Translational Medicine, 8
(341).
341ra76.
doi:10.1126/scitranslmed.aad3744
ISSN 1946-6234.
Abraham, Jean E., Hiller, Louise, Dorling, Leila, Vallier, Anne-Laure, Dunn, Janet A., Bowden, Sarah, Ingle, Susan, Jones, Linda, Hardy, Richard, Twelves, Christopher, Poole, Christopher J., Pharoah, Paul D. P., Caldas, Carlos and Earl, Helena M. (2015) A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine, 13 (1). 306. doi:10.1186/s12916-015-0547-5 ISSN 1741-7015.
Earl, Helena M., Hiller, Louise, Dunn, Janet A., Blenkinsop, Clare, Grybowicz, Louise, Vallier, Anne-Laure, Abraham, Jean, Thomas, Jeremy, Provenzano, Elena, Hughes-Davies, Luke et al.
(2015)
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis) : an open-label, randomised, phase 3 trial.
The Lancet Oncology, 16
(6).
pp. 656-666.
doi:10.1016/S1470-2045(15)70137-3
ISSN 1470-2045.
Pirie, Ailith, Guo, Qi, Kraft, Peter, Canisius, Sander, Eccles, Diana M, Rahman, Nazneen, Nevanlinna, Heli, Chen, Constance, Khan, Sofia, Tyrer, Jonathan et al.
(2015)
Common germline polymorphisms associated with breast cancer-specific survival.
Breast Cancer Research, 17
(1).
58.
doi:10.1186/s13058-015-0570-7
ISSN 1465-542X.
Guo, Q., Schmidt, M. K., Kraft, P., Canisius, S., Chen, C., Khan, S., Tyrer, J., Bolla, M. K., Wang, Q., Dennis, J. et al.
(2015)
Identification of Novel Genetic Markers of Breast Cancer Survival.
JNCI Journal of the National Cancer Institute, 107
(5).
djv081.
doi:10.1093/jnci/djv081
ISSN 0027-8874.
Ali, H. R., Glont, S.- E., Blows, F. M., Provenzano, E., Dawson, S.- J., Liu, B., Hiller, Louise, Dunn, Janet A., Poole, C. J., Bowden, S., Earl, H. M., Pharoah, P. D. P. and Caldas, C. (2015) PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes. Annals of Oncology, 26 (7). doi:10.1093/annonc/mdv192 ISSN 0923-7534.
Ali, H. R., Provenzano, E., Dawson, S.- J., Blows, F. M., Liu, B., Shah, M., Earl, H. M., Poole, C. J., Hiller, Louise, Dunn, Janet A. et al.
(2014)
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.
Annals of Oncology, 25
(8).
pp. 1536-1543.
doi:10.1093/annonc/mdu191
ISSN 0923-7534.
Earl, H. M., Hiller, Louise, Blenkinsop, C., Grybowicz, L., Vallier, A. L., Abraham, J., Thomas, J., Provenzano, E., Hughes-Davies, L., McAdam, K. et al.
(2014)
ARTemis: A randomised trial of bevacizumab with neoadjuvant chemotherapy (NACT) for patients with HER2-negative early breast cancer-Primary endpoint, pathological complete response (pCR).
Journal of Clinical Oncology, 32
(15).
p. 1014.
doi:10.1200/jco.2014.32.15_suppl.1014
ISSN 0732-183X.
Abraham, J. E., Guo, Q., Dorling, L., Tyrer, J., Ingle, S., Hardy, R., Vallier, A.-L., Hiller, Louise, Burns, R., Jones, L., Bowden, S. J., Dunn, Janet A., Poole, C. J., Caldas, C., Pharoah, P. P. D. and Earl, Helena M. (2014) Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel. Clinical Cancer Research, Volume 20 (Number 9). pp. 2466-2475. doi:10.1158/1078-0432.CCR-13-3232 ISSN 1078-0432.
Earl, Helena M., Vallier, Anne-Laure, Hiller, Louise, Fenwick, Nicola, Young, Jennie, Iddawela, Mahesh, Abraham, Jean, Hughes-Davies, Luke, Gounaris, Ioannis, McAdam, Karen et al.
(2014)
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo) : an open-label, 2Γ2 factorial randomised phase 3 trial.
The Lancet Oncology, Volume 15
(Number 2).
pp. 201-212.
doi:10.1016/S1470-2045(13)70554-0
ISSN 1470-2045.
Ali, Alaa M., Provenzano, Elena, Bartlett, John M. S., Abraham, Jean, Driver, Kristy, Munro, Alison F., Twelves, Chris, Poole, Christopher J., Hiller, Louise, Dunn, Janet A., Earl, Helena M., Caldas, Carlos and Pharoah, Paul D. (2013) Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial. International Journal of Cancer, Volume 133 (Number 6). pp. 1470-1478. doi:10.1002/ijc.28150 ISSN 0020-7136.
Provenzano, E., Vallier, A. -L., Champ, R., Walland, K., Bowden, S. (Sarah), Grier, Anna, Fenwick, Nicola, Abraham, J. (Janet), Iddawela, M., Caldas, C., Hiller, Louise, Dunn, Janet A. and Earl, Helena M. (2013) A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. British Journal of Cancer, Volume 108 (Number 4). pp. 866-872. doi:10.1038/bjc.2012.547 ISSN 0007-0920.
Earl, Helena M., Hiller, Louise, Dunn, Janet A., Vallier, A. -L., Bowden, S. J., Jordan, S. D., Blows, F., Munro, A., Bathers, S., Grieve, R. et al.
(2012)
Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer : results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials.
British Journal of Cancer, Vol.107
(No.8).
pp. 1257-1267.
doi:10.1038/bjc.2012.370
ISSN 0007-0920.
Hiller, Louise, Dunn, Janet A., Higgins, Helen B., Ogburn-Storey, Emma, Loi, Shrushma, Vallier, Anne-Laure and Earl, Helena M. (2011) Optimising patient recall of adverse events over prolonged time periods. Trials, Vol.12 (Suppl.1). A74. doi:10.1186/1745-6215-12-S1-A74 ISSN 1745-6215.
Campbell, H. E., Epstein, D., Bloomfield, D., Griffin, S., Manca, A., Yarnold, J., Bliss, J., Johnson, L., Earl, Helena M., Poole, Christopher J., Hiller, Louise, Dunn, Janet A., Hopwood, P., Barrett-Lee, P., Ellis, P., Cameron, D., Harris, A. L., Gray, A. M. and Sculpher, Mark J. (2011) The cost-effectiveness of adjuvant chemotherapy for early breast cancer : a comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. European Journal of Cancer, Vol.47 (No.17). pp. 2517-2530. doi:10.1016/j.ejca.2011.06.019 ISSN 0959-8049.
Gounaris, I., Provenzano, E., Vallier, A. L., Hiller, Louise, Iddawela, M., Hilborne, S., Taylor, K. (Kathryn), Britton, Peter, Earl, Helena M. and Sinnatamby, R. (2011) Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment, Volume 127 (Number 2). pp. 459-469. doi:10.1007/s10549-011-1454-x ISSN 0167-6806.
Hannigan, Adèle, Smith, Paul J., Kalna, Gabriela, Lo Nigro, Cristiana, Orange, Clare, O'Brien, Darren I., Shah, Reshma, Syed, Nelofer, Spender, Lindsay C., Herrera, Blanca et al.
(2010)
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.
Journal of Clinical Investigation, Vol.120
(No.8).
pp. 2842-2857.
doi:10.1172/JCI36125
ISSN 0021-9738.
Bartlett, John M. S., Munro, Alison F., Dunn, Janet A., McConkey, Christopher C., Jordan, S., Twelves, Chris, Cameron, D., Thomas, Jeremy St. J., Campbell, Fiona M., Rea, Daniel W., Provenzano, Elena, Caldas, Carlos, Pharaoh, Paul, Hiller, Louise, Earl, Helena M. and Poole, Christopher (2010) Predictive markers of anthracycline benefit : a prospectively planned analysis of the UK national epirubicin adjuvant trial (NEAT/BR9601). Lancet Oncology, Vol.11 (No.3). pp. 266-274. doi:10.1016/S1470-2045(10)70006-1 ISSN 1470-2045.
Nicholson, Linda J., Smith, Paul R., Hiller, Louise, Szlosarek, Peter W., Kimberley, Christopher, Sehouli, Jalid, Koensgen, Dominique, Mustea, Alexander, Schmid, Peter and Crook, Tim (2009) Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer. International Journal of Cancer, Vol.125 (No.6). pp. 1454-1463. doi:10.1002/ijc.24546 ISSN 0020-7136.
Pepper, Chris, Lin, Thet Thet, Pratt, Guy, Hewamana, Saman, Brennan, Paul , Hiller, Louise, Hills, R., Ward, Rachel, Starczynski, Jane, Austen, Belinda, Hooper, Laura, Stankovic, Tatjana and Fegan, Chris (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood, Vol.112 (No.9). pp. 3807-3817. doi:10.1182/blood-2008-05-157131 ISSN 0006-4971.
Behalf NEAT Investigators (Including: Earl, Helena M., Hiller, Louise, Dunn, Janet A., Bathers, S., Harvey, P., Stanley, A., Grieve, R. J., Agrawal, R. K., Fernando, I. N., Brunt, A. M., McAdam, K., O'Reilly, S., Rea, D. W., Spooner, David A. and Poole, Christopher). (2008) NEAT : national epirubicin adjuvant trial - toxicity, delivered dose intensity and quality of life. British Journal of Cancer, Vol.99 (No.8). pp. 1226-1231. doi:10.1038/sj.bjc.6604674 ISSN 0007-0920.
tAnGo Trial Collaborators (Including: Wardley, A. M., Hiller, Louise, Howard, H. C., Dunn, Janet A., Bowman, A., Coleman, R. E., Fernando, I. N., Ritchie, D. M., Earl, Helena M. and Poole, Christopher J.). (2008) tAnGo : a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer : a prospective pulmonary, cardiac and hepatic function evaluation. British Journal of Cancer, Vol.99 (No.4). pp. 597-603. doi:10.1038/sj.bjc.6604538 ISSN 0007-0920.
Tennant, Ruth, Hiller, Louise, Fishwick, Ruth, Platt, Stephen, Joseph, Stephen, Weich, Scott, Parkinson, Jane, Secker, Jenny and Stewart-Brown, Sarah L. (2007) The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) : development and UK validation. Health and Quality of Life Outcomes, Vol.5 (No.63). doi:10.1186/1477-7525-5-63 ISSN 1477-7525.
Hiller, Louise, Bradshaw, H. D., Radley, S. C. and Radley, S. (2007) Criterion validity of the BBUSQ-22: a questionnaire assessing bowel and urinary tract symptoms in women. International Urogynecology Journal, Vol.18 (No.10). pp. 1133-1137. doi:10.1007/s00192-007-0308-x ISSN 0937-3462.
Donnelly, P., Hiller, Louise, Bathers, S., Bowden, S. and Coleman, R. (2007) Questioning specialistsβ attitudes to breast cancer follow-up in primary care. Annals of Oncology, 18 (9). pp. 1467-1476. doi:10.1093/annonc/mdm193 ISSN 0923-7534.
Smith, Paul, Nicholson, Linda J., Syed, Nelofer, Payne, Annette, Hiller, Louise, Garrone, Ornella, Occelli, Marcella, Gasco, Milena and Crook, Tim (2007) Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes. Clinical Cancer Research, Vol.13 (No.14). pp. 4061-4068. doi:10.1158/1078-0432.CCR-06-3052 ISSN 1078-0432.
Ainsworth, R., Dziedzic, K., Hiller, Louise, Daniels, J., Bruton, A. and Broadfield, J. (2007) A prospective double blind placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder pain. Rheumatology, Vol.46 (No.5). pp. 815-820. doi:10.1093/rheumatology/kel423 ISSN 1462-0324.
Piper, M. K., Raza, K., Nuttall, S. L., Stevens, R., Toescu, V., Heaton, S., Gardner-Medwin, J., Hiller, Louise, Martin, U., Townend, J., Bacon, P. A. and Gordon, Caroline (2007) Impaired endothelial function in systemic lupus erythematosus. Lupus, Vol.16 (No.2). pp. 84-88. doi:10.1177/0961203306074842 ISSN 0961-2033.
Poole, Christopher J., Earl, Helena M., Hiller, Louise, Dunn, Janet A., Bathers, Sarah, Grieve, Robert J., Spooner, David A., Agrawal, Rajiv K., Brunt, A. Murray, OβReilly, Susan M. et al.
(2006)
Epirubicin and cyclophosphamide, methotrexate,
and fluorouracil as adjuvant therapy for early breast cancer.
New England Journal of Medicine, Vol.355
(No.18).
pp. 1851-1862.
doi:10.1056/NEJMoa052084
ISSN 0028-4793.
Pemberton, N. C., Paneesha, S., Hiller, Louise, Starczynski, J., Hooper, L., Pepper, C., Pratt, G. and Fegan, C. (2006) The SDF-1 G > A polymorphism at position 801 plays no role in multiple myeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemia. Leukemia & Lymphoma, 47 (7). pp. 1239-1244. doi:10.1080/10428190600562112 ISSN 1042-8194.
Bradshaw, H. D., Hiller, Louise, Farkas, A. G., Radley, S. and Radley, S. C. (2006) Development and psychometric testing of a symptom index for pelvic organ prolapse. Journal of Obstetrics and Gynaecology Research, 26 (3). pp. 241-252. doi:10.1080/01443610500537989 ISSN 1341-8076.
Hussain, S. A., Palmer, D. H., Ganesan, R., Hiller, Louise, Gregory, J., Murray, P. G., Pastorek, J., Young, L. and James, N. D. (2004) Carbonic anhydrase IX, a marker of hypoxia : correlation with clinical outcome in transitional cell carcinoma of the bladder. Oncology Reports, 11 (5). pp. 1005-1010. doi:10.3892/or.11.5.1005 ISSN 1021-335X.
Sullivan, Alexandra, Syed, Nelofer, Gasco, Milena, Bergamaschi, Daniele, Trigiante, Giuseppe, Attard, Marlene, Hiller, Louise, Farrell, Paul J, Smith, Paul, Lu, Xin and Crook, Tim (2004) Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene, 23 (19). pp. 3328-3337. doi:10.1038/sj.onc.1207428 ISSN 0950-9232.
Hiller, Louise, Bradshaw, H. D., Radley, S. C. and Radley, S. (2003) A scoring system for the assessment of bowel and lower urinary tract symptoms in women. BJOG: An International Journal of Obstetrics and Gynaecology, 109 (4). pp. 424-430. doi:10.1111/j.1471-0528.2002.01236.x ISSN 1470-0328.
Wilson, D., Hiller, Louise, Gray, L., Grainger, M., Stirling, A. and James, N. (2003) The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma. Clinical Oncology, 15 (7). pp. 400-407. doi:10.1016/S0936-6555(03)00164-X ISSN 0936-6555.
Hussain, S. A., Ganesan, R., Hiller, Louise, Cooke, P. W., Murray, P., Young, L. S. and James, N. D. (2003) BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder. Oncology Reports, 10 (3). pp. 571-576. doi:10.3892/or.10.3.571 ISSN 1021-335X.
Bergamaschi, Daniele, Gasco, Milena, Hiller, Louise, Sullivan, Alexandra, Syed, Nelofer, Trigiante, Giuseppe, Yulug, Isik, Merlano, Marco, Numico, Gianmauro, Comino, Alberto et al.
(2003)
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.
Cancer Cell, 3
(4).
pp. 387-402.
doi:10.1016/S1535-6108(03)00079-5
ISSN 1535-6108.
Hussain, S. A., Ganesan, R., Hiller, Louise, Murray, P. G., El-Magraby, M. M., Young, L. and James, N. D. (2003) Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. British Journal of Cancer, 88 (4). pp. 586-592. doi:10.1038/sj.bjc.6600765 ISSN 0007-0920.
Hiller, Louise, Radley, S., Mann, C. H., Radley, S. C., Begum, G., Pretlove, S .J. and Salaman, J. H. (2002) Development and validation of a questionnaire for the assessment of bowel and lower urinary tract symptoms in women. BJOG: An International Journal of Obstetrics and Gynaecology, 109 (4). pp. 413-423. doi:10.1111/j.1471-0528.2002.01147.x ISSN 1470-0328.
Eggar, Richard, Spencer, Amanda, Anderson, David and Hiller, Louise (2002) Views of elderly patients on cardiopulmonary resuscitation before and after treatment for depression. International Journal of Geriatric Psychiatry, 17 (2). pp. 170-174. doi:10.1002/gps.523 ISSN 0885-6230.
Gasco, M., Bell, A. K., Heath, V., Sullivan, A., Smith, P., Hiller, Louise, Yulug, I., Numico, G., Merlano, M., Farrell, P. J., Tavassoli, M., Gusterson, B. and Crook, T. (2002) Epigenetic inactivation of 14-3-3 Ο in oral carcinoma : association with p16INK4a silencing and human papillomavirus negativity. Cancer Research, 62 (7). pp. 2072-2076. ISSN 0008-5472.
Batta, Kapila, Goodyear, Helen M., Moss, Celia, Williams, Hywel C., Hiller, Louise and Waters, Ruth (2002) Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas : results of a 1-year analysis. The Lancet, 360 (9332). pp. 521-527. doi:10.1016/S0140-6736(02)09741-6 ISSN 0140-6736.
Demain, Sara, Smith, Jan Fereday, Hiller, Louise and Dziedzic, Krysia (2001) Comparison of group and individual physiotherapy for female urinary incontinence in primary care. Physiotherapy, 87 (5). pp. 235-242. doi:10.1016/S0031-9406(05)60784-5 ISSN 0031-9406.
Brooks, L. A., Tidy, J. A., Gusterson, B., Hiller, Louise, OβNions, J., Gasco, M., Marin, M. C., Farrell, P. J., Kaelin, Jr. and Crook, T. (2000) Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus. Cancer Research, 60 (24). pp. 6875-6877. ISSN 0008-5472.
Darnton, S. J., Zgainski, B., Grenier, I., Allister, K., Hiller, Louise, McManus, K. G. and Steyn, R. S. (1999) The use of an anabolic steroid (nandrolone decanoate) to improve nutritional status after esophageal resection for carcinoma. Diseases of the Esophagus, 12 (4). pp. 283-288. doi:10.1046/j.1442-2050.1999.00074.x ISSN 1120-8694.
Nicholl, D. J., Bennett, P., Hiller, Louise, Bonifati, V., Vanacore, N., Fabbrini, G., Marconi, R., Colosimo, C., Lamberti, P., Stocchi, F., Bonuccelli, U., Vieregge, P., Ramsden, D. B., Meco, G. and Williams, A. C. (1999) A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. Neurology, 53 (7). pp. 1415-1421. doi:10.1212/WNL.53.7.1415 ISSN 0028-3878.
Etherington, I. J., Luesley, D. M., Shafi, M. I., Dunn, Janet A., Hiller, Louise and Jordan, J. A. (1997) Observer variability among colposcopists from the West Midlands region. BJOG: An International Journal of Obstetrics and Gynaecology, 104 (12). pp. 1380-1384. doi:10.1111/j.1471-0528.1997.tb11007.x ISSN 1470-0328.
Conference Item
Gounaris, I., Sinnatamby, R., Taylor, K., Wallis, M., Hiller, Louise, Vallier, A.-L., Provenzano, E., Iddawela, M., Wishart, G., Earl, Helena M. and Britton, P. (2010) O-31 Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patient. In: 1st British Breast Cancer Research Conference, Nottingham, England, 15-17 Sep 2010. Published in: European Journal of Cancer Supplements, Vol.8 (No.6). p. 12. doi:10.1016/j.ejcsup.2010.06.032 ISSN 13596349.
Earl, Helena M., Vallier, A., Hiller, Louise, Fenwick, N., Iddawela, M., Hughes-Davies, Luke, Provenzano, E., McAdam, K., Hickish, T. and Caldas, C. (2009) Neo-tAnGo: a neoadjuvant randomized phase III trial of epirubicin/cyclophosphamide and paclitaxel +/- gemcitabine in the treatment of women with high-risk early breast cancer (EBC): first report of the primary endpoint, pathological complete response (pCR). In: 45th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, MAY 29-JUN 02, 2009. Published in: Journal of Clinical Oncology, Vol.27 (No.15 Suppl. S). Article: 522. ISSN 0732-183X.
Bartlett, J. M. S., Munro, A., Dunn, Janet A., Hiller, Louise, Jordan, S., Twelves, Chris, Cameron, D. A., Thomas, J., Campbell, F., Rea, D. W., Provenzano, E., Pharoah, P., Caldas, Carlos, Earl, Helena M. and Poole, Christopher J. (2009) Chromosome 17 polysomy (Ch17) as a predictor of anthracycline response: emerging evidence from the UK NEA Tadjuvant breast cancer trial. In: 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 10-14, 2008. Published in: Cancer Research, Vol.69 (No.2 Suppl. S). 74S-74S. doi:10.1158/0008-5472.SABCS-45 ISSN 0008-5472.
Batta, K., Goodyear, H., Moss, C., Williams, Hywel, Hiller, Louise and Waters, Ruth A. (2008) Randomized controlled study of early pulsed dye laser treatment of uncomplicated infantile haemangiomas: results of a 5-year analysis. In: 88th Annual Meeting of the British-Association-of-Dermatologists, Liverpool, England, Jul 01-04, 2008. Published in: British Journal of Dermatology, Volume 159 (Supplement 1). p. 113. ISSN 0007-0963.
Bowden, S., Gross, L., Poole, C. J., Hiller, Louise, Agrawal, R. K., McAdam, K. F., Earl, Helena M., Anwar, S. and Rea, Dean (2007) NEAT-A: accelerated sequential epirubicin followed by higher dose 14 day CMF, using pegfilgrastim, is a feasible alternative for delivering dose dense E-CMF chemotherapy in early breast cancer. In: 14th European Cancer Conference (ECCO 14), Barcelona, Spain, SEP 23-27, 2007. Published in: European Journal of Cancer Supplements, Vol.5 (No.4). pp. 194-195. doi:10.1016/S1359-6349(07)70797-8 ISSN 1359-6349.
Hiller, Louise, Fenwick, N., Vallier, A. L., Dunn, Janet A., Hilborne, S., Jones, L., Abraham, J., Iddawela, M., Caldas, Carlos and Earl, Helena M. (2007) The challenges of using radiological 'tumour response' as an endpoint in Neo-tAnGo: a national neo-adjuvant chemotherapy breast cancer trial. In: 10th Nottingham International Breast Cancer Conference, Nottingham, England, September 18-20, 2007. Published in: European Journal of Cancer Supplements, Vol.5 (No.3). pp. 33-34. doi:10.1016/S1359-6349(07)71800-1 ISSN 1359-6349.
Poole, C. J., Hiller, Louise, Howard, H. C., Loi, Shrushma, Dunn, Janet A., Canney, P., Wardley, A. M., Crown, J. P., Coleman, R. E., Verrill, M. W., Ellis, P. A., Leonard, R. C., Spooner, David A. and Earl, Helena M. (2006) Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer. In: 29th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, DEC 14-17, 2006. Published in: BREAST CANCER RESEARCH AND TREATMENT, 100 (Suppl. 1). S114-S114. ISSN 0167-6806.
Casson, Alan G, Darnton, S.Jane, Subramanian, Sujata and Hiller, Louise (2002) What is the optimal distal resection margin for esophageal carcinoma? In: Thirty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, 25-27 Jan 1999. Published in: The Annals of Thoracic Surgery, 69 (1). pp. 205-209. doi:10.1016/S0003-4975(99)01262-X ISSN 00034975.
Journal Item
Hiller, Louise, Loi, S., Vallier, A. L., Howe, Donna L., Bell, P., Carey, J., Manazar, Uzma, Cameron, D., Miles, D. and Wardley, A. (2017) Measurement methods for eliciting opinions on treatment benefits, toxicities and acceptable trade-offs of the two, within the PERSEPHONE trial. Trials, 18 (Supplement 1). p. 200. P368 [pp139]. ISSN 1745-6215 doi:10.1186/s13063-017-1902-y
Mistry, Pankaj, Hiller, Louise, Iqbal, Gulnaz and Dunn, Janet A. (2015) Under-representation of male patients in breast cancer studies. Trials, 16 (Supplement 2). P110. ISSN 1745-6215 doi:10.1186/1745-6215-16-S2-P110
Hiller, Louise, Marshall, A. (Andrea)β and Dunn, Janet A. (2015) Assessing violations of the proportional hazards assumption in Cox regression : does the chosen method matter? Trials, 16 (Supplement 2). P134. ISSN 1745-6215 doi:10.1186/1745-6215-16-S2-P134
Hiller, Louise, Vallier, A. L., Ogburn, E., Wardley, A. M., Cameron, D. A., Miles, D., Dunn, Janet A. and Earl, H. M. (2014) Cardiology monitoring substudy in the PERSEPHONE trial : 6 versus 12 months of trastuzumab. Journal of Clinical Oncology, 32 (15). p. 1. ISSN 0732-183X doi:10.1200/jco.2014.32.15_suppl.552
Earl, H. M., Vallier, A. L., Ogburn-Storey, E., Cameron, D. A., Wardley, A. M., Miles, D., Loi, S., Hiller, Louise, Higgins, H. B. and Dunn, Janet A. (2013) PERSEPHONE : duration of trastuzumab with chemotherapy in women with HER-2+ve early breast cancer. Cancer Research, 73 (Supplement 24). OT1-1-08. ISSN 0008-5472 doi:10.1158/0008-5472.SABCS13-OT1-1-08
Earl, H. M., Chin, S. F., Dunning, M., Iddawela, M., Rueda, O., Russell, R., Jones, L., Vallier, A. L., Hughes-Davies, L., Abraham, J. et al.
(2013)
Neo-tAnGo science : a translational study of PAM 50 sub-typing in sequential fresh tissue samples during neoadjuvant chemotherapy.
Journal of Clinical Oncology, 31
(15).
1015.
ISSN 0732-183X
doi:10.1200/jco.2013.31.15_suppl.1015
Earl, H. M., Cameron, D. A., Miles, D., Wardley, A. M., Ogburn, E., Vallier, A. L., Loi, S., Higgins, H. B., Hiller, Louise and Dunn, Janet A. (2013) PERSEPHONE : duration of trastuzumab with chemotherapy in women with HER2-positive early breast cancer-six versus twelve months. Journal of Clinical Oncology, 31 (15). p. 1. ISSN 0732-183X doi:10.1200/jco.2014.32.15_suppl.tps656
Wishart, G. C., Benson, J. R., Absar, M. S., Vallier, A. L., Hiller, Louise, Fenwick, N., Champ, R., Provenzano, E., Caldos, C. and Earl, H. M. (2009) Sentinel lymph node biopsy (SLNB) prior to primary chemotherapy (PC) in breast cancer patients. Cancer Research, 69 (2). 334S-334S. ISSN 0008-5472 doi:10.1158/0008-5472.SABCS-5111
Donnelly, Peter K., Hiller, Louise and Dunn, Janet A. (2008) Need for the iBreast trial β risk adjusted breast cancer follow-up trial. BMJ . ISSN 0959-535X
Donnelly, Peter K., Hiller, Louise and Dunn, Janet A. (2008) Follow-up after breast cancer : national randomised controlled trial is needed. British Medical Journal, Vol.336 (No.7642). pp. 461-462. ISSN 0959-8146 doi:10.1136/bmj.39500.469664.1F
Ainsworth, R., Dziedzic, K., Hiller, Louise, Daniels, J., Bruton, A. and Broadfield, J. (2007) Comment on : a prospective double blind placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder pain : reply. Rheumatology, Vol.47 (No.2). pp. 230-231. ISSN 1462-0324 doi:10.1093/rheumatology/kem340
Wilson, D., Hiller, Louise and Geh, J. I. (2005) Review of second-line chemotherapy for advanced gastric adenocarcinoma. Clinical Oncology, 17 (2). pp. 81-90. ISSN 0936-6555 doi:10.1016/j.clon.2004.10.006
Wilson, D., Hiller, Louise and Geh, I. (2004) ECF in gastric cancer. Clinical Oncology, 16 (5). pp. 381-382. ISSN 0936-6555 doi:10.1016/j.clon.2004.05.006
This list was generated on Sat Apr 20 05:26:47 2024 BST.